10.03
Anteris Technologies Global Corp stock is traded at $10.03, with a volume of 667.94K.
It is down -5.11% in the last 24 hours and up +4.05% over the past month.
Anteris Technologies Global Corp is a structural heart company focused on advancing cardiac care through science-driven innovations aimed at restoring heart valve patients to healthy function. Its key product, the DurAVR Transcatheter Heart Valve (THV), was designed in partnership with interventional cardiologists and cardiac surgeons to treat Aortic Stenosis, a potentially life-threatening condition caused by narrowing of the aortic valve. The balloon-expandable DurAVR THV is a biomimetic valve designed to mimic the performance of a healthy human aortic valve and replicate normal aortic blood flow. The company operates in United States, Germany, Australia, Switzerland, and Sweden, with the majority of its revenue generated from the United States.
See More
Previous Close:
$10.57
Open:
$10.635
24h Volume:
667.94K
Relative Volume:
0.59
Market Cap:
$974.40M
Revenue:
$1.85M
Net Income/Loss:
$-95.19M
P/E Ratio:
-4.5144
EPS:
-2.2208
Net Cash Flow:
$-86.88M
1W Performance:
+1.83%
1M Performance:
+4.05%
6M Performance:
+102.63%
1Y Performance:
+188.22%
Anteris Technologies Global Corp Stock (AVR) Company Profile
Name
Anteris Technologies Global Corp
Sector
Industry
Phone
651-493-0606
Address
860 BLUE GENTIAN ROAD, EAGAN
Compare AVR vs ISRG, BDX, MDLN, ALC, RMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
AVR
Anteris Technologies Global Corp
|
10.01 | 1.03B | 1.85M | -95.19M | -86.88M | -2.2208 |
|
ISRG
Intuitive Surgical Inc
|
426.08 | 153.29B | 10.58B | 3.00B | 2.83B | 8.2437 |
|
BDX
Becton Dickinson Co
|
157.25 | 42.86B | 21.37B | 1.41B | 3.07B | 3.9437 |
|
MDLN
Medline Inc
|
42.97 | 36.15B | 29.14B | 1.07B | 1.05B | 1.1956 |
|
ALC
Alcon Inc
|
67.11 | 33.32B | 10.63B | 819.00M | 1.59B | 1.6577 |
|
RMD
Resmed Inc
|
218.78 | 31.68B | 5.54B | 1.52B | 1.74B | 10.37 |
Anteris Technologies Global Corp Stock (AVR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-12-26 | Resumed | Cantor Fitzgerald | Overweight |
| Mar-11-26 | Initiated | Wells Fargo | Overweight |
| Jan-08-25 | Initiated | Lake Street | Buy |
| Jan-07-25 | Initiated | Barclays | Overweight |
| Jan-07-25 | Initiated | Cantor Fitzgerald | Overweight |
| Jan-07-25 | Initiated | TD Cowen | Buy |
View All
Anteris Technologies Global Corp Stock (AVR) Latest News
ChartWatch ASX Scans: CSL, Cochlear, Artrya, Anteris Technologies, AMP, Zip Co, Graincorp, Pexa - Market Index
Anteris Technologies files form S-3 to register 5.39M shares via warrants - MSN
Could Anteris Technologies Global Corp (ASX:AVR) Continue Its Momentum After 162% One-Year Rally? - Kalkine
Anteris Technologies Reports Net CDI Reduction of 51,701 as Holders Shift to Nasdaq Common Stock in June 2026 - Kalkine
Anteris adjusts CDI and common stock balances amid ASX–Nasdaq transfers - TipRanks
Anteris Technologies Sees 51,701 Net CDI Decrease in June 2026 as Investors Shift Holdings to Nasdaq Shares - Kalkine Media
Anteris Files Shelf Registration to Support Advanced Heart Valve Portfolio - TipRanks
Anteris Technologies Files Offering of Up to 5.39 Million Shares - Moomoo
Anteris Technologies Reports Lapse of Restricted Stock Units and Options - TipRanks
Anteris Technologies Global Corp.(NasdaqGM:AVR) added to Russell Microcap Value Benchmark Index - marketscreener.com
Anteris Technologies Global Corp.(NasdaqGM:AVR) added to Russell 2000 Value Benchmark - marketscreener.com
Anteris Technologies Global Corp.(NasdaqGM:AVR) dropped from Russell Microcap Growth Benchmark Index - marketscreener.com
Anteris Technologies Global Corp.(NasdaqGM:AVR) dropped from Russell 2000 Growth Benchmark - marketscreener.com
Anteris Technologies Global Corp.(NasdaqGM:AVR) dropped from Russell 3000E Growth Benchmark - marketscreener.com
Anteris Technologies Global Corp.(NasdaqGM:AVR) added to Russell 3000 Value Benchmark - marketscreener.com
Price to earnings forward of Anteris Technologies Global Corp. – NASDAQ:AVR - TradingView
Price to earnings forward of Anteris Technologies Global Corp. – BOATS:AVR - TradingView
Enterprise value to EBITDA forward of Anteris Technologies Global Corp. – NASDAQ:AVR - TradingView
Anteris Technologies Global Corp. Actuals & Estimates (NASDAQ:AVR) - TradingView
AVR Forecast — Price Target — Prediction for 2027 - TradingView
Price to book forward of Anteris Technologies Global Corp. – NASDAQ:AVR - TradingView
Price to sales forward of Anteris Technologies Global Corp. – NASDAQ:AVR - TradingView
Anteris Issues 45,631 New Shares from Conversion of Unquoted Securities - TipRanks
Anteris adds 23,072 new CDIs to ASX listing - TipRanks
Anteris Technologies Global Corp (AVR) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Anteris Technologies Global Corp (AVR) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Anteris Technologies Global Corp.(NasdaqGM:AVR) added to S&P Healthcare Equipment Select Industry Index - marketscreener.com
Anteris director David Roberts converts RSUs into common stock under long-term incentive plan - TipRanks
Anteris Technologies (AVR) Proxy filing Summary - Quartr
Anteris Technologies Global Corp (AVR) Institutional Confidence - TradingKey
Anteris Technologies Global Corp (AVR) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Anteris Technologies Global Corp (AVR) Valuation: PE, PB & Fair Value Analysis - TradingKey
Anteris Technologies Global Corp (AVR) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Anteris Technologies Global Corp (AVR) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Anteris Technologies Global Corp (AVR) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Anteris Technologies Global Corp - TradingKey
Anteris Technologies (AVR) Surges 3.13% as Shares Approach Key Resistance at $10.04Moving Average Crossovers - dars.gov.et
Anteris Technologies Global Corp. (AVR) Q1 2026 Earnings: Wider-than-Expected Losses as Development Pipeline ProgressesPretax Income Report - newsline.com
Anteris Technologies Global Corp. (AVR) Q1 2026 Earnings: Wider-than-Expected Loss Reflects Continued Clinical InvestmentCore Business Growth - newsline.com
Funds from operations of Anteris Technologies Global Corp. – NASDAQ:AVR - TradingView
Anteris Technologies (AVR) director exercises 17,580 RSUs into common shares - Stock Titan
Anteris (AVR) CFO exercises options, delivers 39,595 shares for taxes - Stock Titan
AVR Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Anteris Technologies Global Corp. (AVR) Q1 2026 Earnings: EPS Misses Estimates Significantly Amid Continued R&D InvestmentGAAP Earnings Report - newsline.com
Anteris Advances DurAVR Program Through ASX 300 Expansion - Kalkine Media
Anteris Technologies Secures French Regulatory Approval to Begin Paradigm Trial Recruitment; Shares Fall 6% - marketscreener.com
Update: Anteris Technologies Secures French Regulatory Approval to Begin Paradigm Trial Recruitment; Shares Fall 6% - Moomoo
Anteris Technologies Global Corp Gets French Regulatory Clearance For Duravr Paradigm Global Pivotal Trial - TradingView
Anteris Wins French Clearance to Expand Global DurAVR Heart Valve Trial - TipRanks
France clearance marks key milestone for Anteris' pivotal PARADIGM Trial - Yahoo Finance
Anteris Technologies Secures French Regulatory Approval to Begin Paradigm Trial Recruitment - marketscreener.com
Anteris Technologies Global Corp Stock (AVR) Financials Data
Revenue
Net Income
Cash Flow
EPS
Anteris Technologies Global Corp Stock (AVR) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Knight Susan Elizabeth | Director |
Jun 02 '26 |
Buy |
9.29 |
11,000 |
102,228 |
11,000 |
| L1 Capital Pty Ltd | 10% Owner |
Jan 22 '26 |
Buy |
5.75 |
5,000,000 |
28,750,000 |
13,219,814 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):